These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 5598796

  • 1. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF, Neĭfakh SA, Butomo IV, Mashkov BA, Lapchenkov VI.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract] [Full Text] [Related]

  • 2. Evolution of the hepatic lesion in Wilson's disease (hepatolenticular degeneration).
    Sternlieb I.
    Prog Liver Dis; 1972; 4():511-25. PubMed ID: 4569009
    [No Abstract] [Full Text] [Related]

  • 3. Observations on copper metabolism in Wilson's disease.
    Czlonkowska A, Galewicz A, Rodo M, Wehr H.
    Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768
    [No Abstract] [Full Text] [Related]

  • 4. [Kinetics of radioactive copper in Wilson's disease].
    Willvonseder R, Goldstein NP, Tauxe WN.
    Wien Z Inn Med; 1973; 54(5):226-33. PubMed ID: 4790777
    [No Abstract] [Full Text] [Related]

  • 5. Incorporation of radiocopper into ceruloplasmin in normal subjects and in patients with primary biliary cirrhosis and Wilson's disease.
    Vierling JM, Shrager R, Rumble WF, Aamodt R, Berman MD, Jones EA.
    Gastroenterology; 1978 Apr; 74(4):652-60. PubMed ID: 631501
    [No Abstract] [Full Text] [Related]

  • 6. Determination of liver enzymes, serum ceruloplasmin and urine copper in parents of children with Wilson's disease.
    Haghighat M, Dehghani SM, Imanieh MH, Gholami S.
    Saudi Med J; 2008 Jul; 29(7):1056-7. PubMed ID: 18626543
    [No Abstract] [Full Text] [Related]

  • 7. [Copper and its compounds in physiological and pathological conditions].
    Pawlak J.
    Wiad Lek; 1975 Jun 01; 28(11):949-52. PubMed ID: 1136458
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Turnover studies of copper in homozygotes and heterozygotes for Wilson's disease and controls: isotope tracer studies with 67 Cu.
    Strickland GT, Beckner WM, Leu ML, O'Reilly S.
    Clin Sci; 1972 Nov 01; 43(5):605-15. PubMed ID: 5083936
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Detection of the heterozygote of Wilson's disease.
    O'Reilly S, Weber P, Pollycove M, Shipley L.
    J Nucl Med; 1969 Mar 01; 10(3):143-4. PubMed ID: 5785018
    [No Abstract] [Full Text] [Related]

  • 19. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T, Tirouche YD, Abaoub-Germain A, Theodore F.
    Encephale; 2007 Dec 01; 33(6):924-32. PubMed ID: 18789784
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.